XML 47 R37.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Note 7 - Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares | 6 Months Ended
--- | ---
Jun. 30, 2024 | Jun. 30, 2023
Share-Based Payment Arrangement, Option [Member] |  |  |
Antidilutive Securities (in shares) |  | 10,000 | 10,000
Convertible Series F Preferred Stock [Member] |  |  |
Antidilutive Securities (in shares) | [1] | 1,964,986 | 3,728,070
Series F Preferred Warrants [Member] |  |  |
Antidilutive Securities (in shares) | [2] | 111,396,848 | 19,152,047
Common Stock Warrants [Member] |  |  |
Antidilutive Securities (in shares) | [3] | 5,101,345 | 4,139,784
[1] | Calculation assumes conversion of the stated value, and accrued dividends, of the Series F Preferred Stock into Common Stock at the Floor Price as of June 30, 2024, and at the initial conversion price of $1.71 as of June 30, 2023.
[2] | Calculation assumes exercise of the Series F Preferred Warrants for cash into Series F Preferred Stock and subsequent conversion of the Series F Preferred Stock into Common Stock at the Floor Price as of June 30, 2024 and at the initial conversion price of $1.71 as of June 30, 2023.
[3] | Calculation does not include the 963,745 Common Warrants issued during the three and six months ended June 30, 2024, as they were not exercisable as of June 30, 2024.

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=oblg_ConvertibleSeriesFPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=oblg_SeriesFPreferredWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=oblg_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |